These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20402712)

  • 41. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.
    Szegedi A; Zhao J; McIntyre RS
    J Affect Disord; 2013 Sep; 150(3):745-52. PubMed ID: 23473546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder.
    Petrikis P; Andreou C; Bozikas VP; Karavatos A
    Can J Psychiatry; 2004 Aug; 49(8):572-3. PubMed ID: 15453108
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG; Kochman F; Demonfaucon C; Barrot I; Millet B; Lancrenon S; Akiskal HS
    Encephale; 2002; 28(1):21-8. PubMed ID: 11963340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
    Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
    J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olanzapine in the treatment of adolescent acute mania: a report of seven cases.
    Soutullo CA; Sorter MT; Foster KD; McElroy SL; Keck PE
    J Affect Disord; 1999 Jun; 53(3):279-83. PubMed ID: 10404715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
    Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
    Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
    Berk M; Ichim L; Brook S
    Int Clin Psychopharmacol; 1999 Nov; 14(6):339-43. PubMed ID: 10565800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Maina G; Ghaemi SN
    J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.
    van Oppen P; van Balkom AJ; de Haan E; van Dyck R
    J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Canadian naturalistic study of a community-based cohort treated for bipolar disorder.
    Sagman D; Lee B; Chandresena R; Jones B; Brunner E
    BMC Psychiatry; 2010 Mar; 10():24. PubMed ID: 20302634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and familial profile of bipolar disorder with and without obsessive-compulsive disorder: an Indian study.
    Kazhungil F; Cholakottil A; Kattukulathil S; Kottelassal A; Vazhakalayil R
    Trends Psychiatry Psychother; 2017; 39(4):270-275. PubMed ID: 29267510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders.
    Chen YW; Dilsaver SC
    Psychiatry Res; 1995 Nov; 59(1-2):57-64. PubMed ID: 8771221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
    Berk M; Ng F; Wang WV; Calabrese JR; Mitchell PB; Malhi GS; Tohen M
    J Affect Disord; 2008 Feb; 106(1-2):153-8. PubMed ID: 17655936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder.
    Dar SA; Wani RA; Haq I
    Psychiatr Q; 2021 Dec; 92(4):1413-1424. PubMed ID: 33830427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.